T0	Participants 53 119	cancer patients treated with autologous stem cell transplantation:
T1	Participants 313 378	cancer patients treated with autologous stem cell transplantation
T2	Participants 691 721	whereas extended care patients
T3	Participants 1012 1281	RESULTS Thirty-seven patients consented to participate in the study (54% male; mean age 58.7 ± 9.5 years; median body mass index 26.8 kg m(-2) , range 16.4-47.6 kg m(-2) ); 33 patients completed the study and 28 patients returned the questionnaire (response rate = 85%)
T4	Participants 1654 1673	difference = 0.56).
T5	Participants 1674 1735	CONCLUSIONS Cancer patients treated with autologous stem cell
T6	Participants 1782 1806	extended nutrition care.
T7	Participants 1807 1815	Extended